Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The dose will be increased.
B The medication will be stopped.
C The dose will be decreased.
D The dose will be unchanged.
Question #2
A Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
B Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
C Not a candidate for fondaparinux based on an insufficient creatinine clearance
D Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
Question #3
A Too high
B Too low
C Inadequate to evaluate treatment
D Within normal limits
Question #4
A Significantly decreased
B Inadequate to evaluate treatment
C Within normal limits
D Significantly elevated
Question #5
A Administer prescribed vitamin K if bruising is observed.
B Monitor liver enzymes.
C Assess for dysrhythmias.
D Stop the medication if the systolic blood pressure drops below 110 mm Hg.
Question #6
A Administering the medication when convenient
B Administering the medication intramuscularly in the vastus lateralis
C Massaging the site after the injection
D Checking if the patient’s prescription contains enoxaparin
Question #7
A “I take ginkgo supplements for memory enhancement.”
B “I do not take aspirin for pain relief.”
C “I refrain from drinking coffee and citrus fruit juices daily.”
D “I eat 1 cup of green leafy vegetables daily.”
Question #8
A “I get up and walk around at least once an hour.”
B “I never sit with my legs crossed at the knees.”
C “I’ve been on prolonged bed rest.”
D “I avoid tight-fitting stockings or leggings.”
Question #9
A Aminocaproic acid
B Alteplase
C Tranexamic acid
D Phytonadione
Question #10
A Carbamazepine
B Cholestyramine
C Barbiturate
D Cimetidine
Question #11
A Heart rate, Hemoglobin, Blood pressure
B Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
C Platelet count, Heart rate, Blood pressure
D Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A “I will take the medication with food.”
B “I will place the pills in an organizer for easy use.”
C “I will use the medication within 60 days after it is opened.”
D “I will store the bottle in a dry place.”
Question #13
A Creatinine clearance of 25 mL/min
B Diagnosis of diabetes mellitus
C Platelet count of 80,000/mm3
D Loss of 10 pounds
Question #14
A The dosage of the warfarin will be increased by half.
B The dosage of the amiodarone will be increased by half.
C The dosage of the warfarin will be decreased by half.
D The dosage of the amiodarone will be decreased by half.
Question #15
A Continue to administer cimetidine with each dose of warfarin.
B Monitor the patient for decreased action of the anticoagulant.
C Monitor the patient for increased action of the anticoagulant.
D Instruct the patient to notify the nurse if he or she begins to experience discomfort.
Question #16
A Gastrointestinal bleed
B Peptic ulcer disease
C Severe chest pain for the past 2 hours
D Local thrombosis from a peripheral intravenous line
Question #17
A Stop the medication.
B Notify the health care provider immediately.
C Monitor the patient and check the therapeutic range.
D Increase the dose of heparin.
Question #18
A Within the expected target therapeutic level of anticoagulation
B Cannot be interpreted without knowing the prothrombin time and international normalized ratio
C Outside the expected target therapeutic level of anticoagulation; it is too high
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #19
A Hemoglobin level: 11 g/dL
B Prothrombin time: 13 sec
C Platelet count: 100,000/mm3
D Leukocyte count: 3000 cells/mm3
Question #20
A Peptic ulcer disease, Chronic kidney disease
B Atrial fibrillation, History of myocardial infarction
C History of myocardial infarction, Chronic obstructive pulmonary disease
D Chronic obstructive pulmonary disease, Atrial fibrillation
Question #21
A Potassium level of 3.5 mEq/L
B Activated partial thromboplastin time (aPTT) of 37 seconds
C International normalized ratio (INR) of 1
D Platelet count of 95,000/mm3
Question #22
A The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
B Outside the expected target therapeutic level of anticoagulation; it is too high
C Within the expected target therapeutic level of anticoagulation
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A “Refrigerate and keep away from direct sunlight.”
B “Discard the drug within 21 days of opening the original container.”
C “Remove from the original package and place in aluminum foil.”
D “Store the drug with the desiccant-drying agent in the packing cap.”
Question #24
A Amiodarone
B Enoxaparin
C Furosemide
D Ketoconazole
Question #25
A Ensure that a loading dose was initially administered when beginning
B Have protamine sulfate readily available at all times.
C Monitor the patient’s laboratory values correctly.
D Teach the patient about dietary restrictions while on the medication.
Question #26
A Stop the intravenous (IV) drip.
B Wait for the INR to decrease.
C Administer vitamin K1 (phytonadione) IV.
D Administer protamine sulfate IV.
Question #27
A Dissolution of the clot that caused the heart attack
B Reversal of damage from the infarction
C A quick decrease in pain
D Prevention of new clots from forming
Question #28
A “I should follow a low-cholesterol diet during the therapy.”
B “I should not use any acetaminophen during the therapy.”
C “I should refrain from eating broccoli during the therapy.”
D “I should take oral contraceptives during the therapy.”
Question #29
A “I should use a soft toothbrush for dental hygiene.”
B “I should keep taking ibuprofen for my arthritis.”
C “I will double my dose if I forget to take it the day before.”
D “I should decrease the dose if I start bruising easily.”
Question #30
A “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
B “The only difference is that regular heparin dosing is based on the patient’s weight.”
C “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
D “There is no real difference; dalteparin is interchangeable with regular heparin.”
Question #31
A Rub the administration site after injecting.
B Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
C Administer the medication into subcutaneous tissue of the abdomen.
D Utilize the Z-track method to inject the medication.
Question #32
A “I will avoid contact sports.”
B “I will contact my health care provider if I develop excessive bruising.”
C “I will take my medication at the same time each day.”
D “I will increase dark green leafy vegetables in my diet.”
Question #33
A Vitamin E
B Protamine sulfate
C Calcium gluconate
D Vitamin K
Question #34
A Aspirin daily (i.e., 81 mg)
B Vitamin K daily
C Warfarin daily
D Recombinant factors
Question #35
A Acute unstable angina
B Transient ischemic attack
C Vitamin K deficiency
D Peripheral vascular disease
Question #36
A Enoxaparin intramuscularly
B Dabigatran orally
C Warfarin orally
D Heparin subcutaneously
Question #37
A Ingestion of acetaminophen
B Over-the-counter medications
C Urine culture
D Platelet level
Question #38
A September 15
B August 29
C July 31
D October 1
Question #39
A Edema
B Itching
C Nausea
D Chest pain
Question #40
A Blood urea nitrogen (BUN) level of 12 mg/dL
B International normalized ratio (INR) of 1.0
C Activated partial thromboplastin time (aPTT) of 120 seconds
D Platelet count of 150,000 mm3
Question #41
A Creatinine clearance value of 40 mL/min
B Platelet count of 75,000 cell/μL
C Hemoglobin level of 16.5 g/dL
D Fasting blood glucose level of 95 mg/dL
Question #42
A Vitamin K
B Antithrombin III
C Thrombin
D Factor Xa
Question #43
A Alteplase
B Aminocaproic acid
C Desmopressin
D Tranexamic acid
Question #44
A Antifibrinolytic
B Thrombolytic
C Anticoagulant
D Antiplatelet
Question #45
A Acute myocardial infarction
B Heart failure
C Coronary artery disease
D Cardiomyopathy
Question #46
A Aspirin
B Pentoxifylline
C Cilostazol
D Dipyridamole
Question #47
A Fondaparinux
B Dabigatran
C Enoxaparin
D Argatroban
Question #48
A Selective factor Xa inhibitors
B Warfarin
C Heparins
D Direct thrombin inhibitors
Question #49
A Anticoagulants alter platelet function.
B Anticoagulants dissolve clots.
C Anticoagulants prevent clots from forming.
D Anticoagulants interfere with drug metabolism.
Question #50
A Antiplatelet
B Antifibrinolytic
C Thrombolytic
D Anticoagulant
Question #51
A Medication reaction
B Anxiety
C Fatigue from walking with pain
D Embolus to the lungs
Question #52
A Administering vitamin K1
B Administering protamine sulfate
C Infusing 50 mL of warfarin sodium
D Increasing the dose of enoxaparin
Question #53
A Potassium
B Calcium
C Vitamin K
D Aspirin